Multiple Sclerosis Trial, Recruiting ISRCTN10285713 Sponsor: Nottinghamshire Healthcare NHS Foundation Trust Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

ISRCTN10285713
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

  • People who are able and willing to give their consent to take part, and who can communicate in English (information sheets may be available in Welsh on request, but the tests used require English).
  • Part 1 – People with MS: People who have been diagnosed with Multiple Sclerosis (MS) and are aged 18 or older.
  • Part 2 – People with MS: People aged 18 or older with a diagnosis of MS who have already completed the cognitive (thinking and memory) screening in Part 1, and where the clinical team identified mild or moderate cognitive difficulties based on their test scores and conversations with their care team.
  • Part 3 – People with MS: People with MS who took part in Part 2 of the study.
  • Part 3 – Healthcare staff: Nurses, doctors, therapists, or other healthcare professionals involved in delivering the NEuRoMS screening or treatment programme to people with MS in Parts 1 and 2.
  • Part 4 – People with MS: People with MS who took part in Part 2 of the study (and did not take part in Part 3 interviews).
  • Part 4 – Healthcare staff and service planners: Healthcare professionals involved in the NEuRoMS programme, as well as people who work in NHS service planning and commissioning roles.

Who may not be able to join:

  • People who do not have the mental capacity to give their own consent to take part in the study.
  • People taking part in Part 2 who are currently receiving a specialist psychological therapy aimed at treating cognitive (thinking or memory) difficulties.
  • People taking part in Part 2 who have already received the NEuRoMS intervention during earlier phases of the research (referred to as WP2ii or WP3) (confirm with trial site).
  • People with MS taking part in Part 3 who have already participated in the Part 4 interviews.
  • People with MS taking part in Part 4 who have already participated in the Part 3 interviews.

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from the ISRCTN registry. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 10 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nottinghamshire Healthcare NHS Foundation Trust
Registry
ISRCTN registry
Start date
1 June 2024
Est. completion
31 July 2027

Where this trial is recruiting

England 🇬🇧 United Kingdom Wales

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from the ISRCTN registry: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ISRCTN ↗

Source: ISRCTN registry (isrctn.com), data processed 10 July 2026. ISRCTN metadata is CC0; contribution content is CC BY 4.0.